Predicting and protecting hematopoietic stem cells from radiation damage during cancer treatment

Oncologists and radiologists struggle to protect bone marrow stem cells from radiation toxicity during cancer therapy, leading to severe complications like aplastic anemia and immunosuppression. Current clinical practice lacks precise methods to identify which cells within bone marrow niches are most vulnerable, forcing doctors to use conservative dosing that reduces treatment efficacy. Researchers need better understanding of radio-sensitivity variations in different bone marrow cell populations to optimize radiation protocols without sacrificing therapeutic outcomes.